Tolterodine Tartrate Capsules
Function and Efficacy
Not yet clear.
Ingredients
Tolterodine tartrate.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Tolterodine tartrateIngredients |
Not yet clear More |
124937-52-6 | 38 |
Appearance
This product is in the form of capsules.
Indication
This product is suitable for the treatment of overactive bladder, the symptoms of which may include urinary urgency, frequent urination, and urge urinary incontinence.
Usage and Dosage
Oral administration: the recommended dose is 4 mg once a day.
Adverse Reactions
The side effects of this product are generally tolerable and disappear after stopping the drug. This product has mild to moderate anticholinergic effects and may cause dry mouth, indigestion and reduced tears.
Precautions
1. Patients with urinary retention, gastric stagnation, and uncontrolled narrow-angle glaucoma are contraindicated. 2. Patients with confirmed allergic reactions to this product are contraindicated. 3. Patients with myasthenia gravis, severe ulcerative colitis, and toxic megacolon are contraindicated.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.
Drug Interactions
When co-administered with other drugs with anticholinergic effects, the therapeutic effect can be enhanced but also the adverse reactions. Conversely, muscarinic receptor agonists can reduce the efficacy of this product. Other drugs may interact pharmacokinetically with this product because they require cytochrome P4502D6 (CYP2D6) or CYP3A4 for metabolism or can inhibit cytochrome activity. For example, co-administration with fluoxetine (fluoxetine is a strong inhibitor of CYP2D6, and fluoxetine is metabolized to norfluoxetine, which is an inhibitor of CYP3A4) can slightly increase the amount of unbound tolterodine and its 5-hydroxymethyl metabolite, but this does not cause an interaction of obvious clinical significance. If stronger CYP3A4 inhibitors such as macrolide antibiotics (erythromycin and clarithromycin), anti-
Storage
Seal tightly and store at room temperature.
Packaging Specification
2mg
Validity Period
24 months
Manufacturer
Anhui Globe Pharmaceutical Co., Ltd.
-
Founded in:
2000-11-13 -
Address:
No. 3809 Huangshan Avenue, Bengbu City -
Tax NO.:
91340300723348633W -
Registered Funds:
98.5 million yuan -
Website:
-
Email: